Evidence map›Paper›PMID 32115518›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Successful Introduction of Peritoneal Dialysis in an End-stage Renal Failure Patient with Idiopathic Aplastic Anemia.

Yasuhiro Suzuki, Masashi Mizuno, Fumiko Sakata, Hiroshi Kojima, Yuka Sato, Mayuko Kishimoto, Nobuaki Suzuki, Hiroshi Kinashi, Shoji Saito, Takayuki Katsuno and 5 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Yasuhiro SuzukiRenal Replacement Therapy, Nagoya University Graduate School of Medicine, Japan.
Masashi MizunoRenal Replacement Therapy, Nagoya University Graduate School of Medicine, Japan.
Fumiko SakataRenal Replacement Therapy, Nagoya University Graduate School of Medicine, Japan.
Hiroshi KojimaRenal Replacement Therapy, Nagoya University Graduate School of Medicine, Japan.
Yuka SatoRenal Replacement Therapy, Nagoya University Graduate School of Medicine, Japan.
Mayuko KishimotoDepartment of Transfusion Medicine, Nagoya University Graduate School of Medicine, Japan.
Nobuaki SuzukiDepartment of Transfusion Medicine, Nagoya University Graduate School of Medicine, Japan.
Hiroshi KinashiDepartment of Nephrology and Rheumatology, Aichi Medical University, Japan.
Shoji SaitoDivision of Nephrology, Nagoya University Graduate School of Medicine, Japan.
Takayuki KatsunoDepartment of Nephrology and Rheumatology, Aichi Medical University, Japan.
Tomoki KosugiDivision of Nephrology, Nagoya University Graduate School of Medicine, Japan.
Shoichi MaruyamaDivision of Nephrology, Nagoya University Graduate School of Medicine, Japan.
Makoto MurataDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan.
Hitoshi KiyoiDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan.
Yasuhiko ItoDepartment of Nephrology and Rheumatology, Aichi Medical University, Japan.
Nagoya University · JPAichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 45-year-old man with idiopathic aplastic anemia required renal replacement therapy (RRT) due to end-stage renal disease (ESRD). We succeeded in inserting the peritoneal dialysis (PD) catheter under cover of frequent red blood cell and platelet infusions because of severe pancytopenia. During the one-year period after starting PD using an ultraviolet-ray sterilization device, he developed severe leukopenia but no PD-related peritonitis or exit site/tunnel infection until he died of pneumonia. This case suggests that PD might be a suitable choice as RRT in ESRD patients with aplastic anemia, even in those with severe pancytopenia.

Indexed as

Anemia, AplasticCatheterizationCatheters, IndwellingErythrocyte TransfusionHumansKidney Failure, ChronicMaleMiddle AgedPancytopeniaPeritoneal DialysisPeritonitisPlatelet Transfusionaplastic anemiaend stage renal diseaseperitoneal dialysisrenal replacement therapy

Identifiers

PMID32115518
PMCPMC7086332
OpenAlexW3007760577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.